Abstract
Urinary tract infections (UTIs) are among the most common bacterial infections, and the increasing antimicrobial resistance of uropathogens progressively limits the options for empirical therapy. The aim of this study was to determine the spectrum of bacteria causing UTIs in outpatients of City Clinical Hospital No. 1 (Tashkent, Uzbekistan) and to evaluate their susceptibility to commonly used antibiotics. Sixty urine samples from patients with clinically diagnosed UTI and significant bacteriuria (≥105 CFU/mL) were cultured, and the isolates were identified by MALDI-TOF mass spectrometry. The susceptibility of the predominant isolates to ten antibiotics belonging to seven classes was determined by the disc diffusion method. Women accounted for 56.7% of the patients, and the mean age was 38.82 ± 15.3 years. Gram-positive and Gram-negative bacteria represented 52% and 48% of the isolates, respectively. Escherichia coli (43%) was the most frequent uropathogen, followed by Staphylococcus haemolyticus (35%) and Staphylococcus aureus (10%). None of the tested isolates produced an inhibition zone with oxacillin or ampicillin, and most were resistant to piperacillin and co-trimoxazole, whereas tetracycline produced inhibition zones against all isolates. The S. aureus, Enterococcus faecalis and Klebsiella pneumoniae isolates showed no inhibition by agents of three or more antimicrobial classes, consistent with a multidrug-resistant phenotype. These results suggest that resistance to commonly used antibiotics is frequent among uropathogens in this clinical setting and support the use of urine culture and susceptibility testing before treatment.References
1. Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: a worldwide report. Frontiers in Public Health.
2. Bono MJ, Leslie SW, Reygaert WC. Uncomplicated urinary tract infections. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
3. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology. 2015;13(5):269–284.
4. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655.
5. World Health Organization. WHO Bacterial Priority Pathogens List, 2024. Geneva: World Health Organization; 2024.
6. Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: relationship with urinary tract infections. International Journal of Health Sciences (Qassim). 2019;13(2):48–55.
7. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clinical Infectious Diseases. 1999;29(4):745–758.
8. Livermore DM, Pearson A. Antibiotic resistance: location, location, location. Clinical Microbiology and Infection. 2007;13(Suppl 2):7–16.
9. Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, et al. Gender age-dependent etiology community-acquired urinary tract infections. ScientificWorldJournal. 2012;2012:349597.
10. European Association of Urology. EAU Guidelines on Urological Infections. Arnhem: EAU Guidelines Office; 2024.
11. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology. 1966;45(4):493– 496.
12. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant pandrug-resistant bacteria: international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection. 2012;18(3):268–281.
13. Abdunabiev AM, Abduvohidova YO, Turayev AA, Urmonalieva ShU, Ermatova XY, Reyimbergenova ZA, et al. Antimicrobial activity of Lactobacillus strains against urinary tract infections. Xorazm Ma’mun akademiyasi axborotnomasi. 2024;(9/1):16–21.
14. Haghi-Ashtiani MT, Sadeghifard N, Abedini M, Soroush S, Taheri-Kalani M. Etiology and antibacterial resistance of bacterial urinary tract infections in children’s Medical Center, Tehran, Iran. Acta Medica Iranica. 2007;45(2):153–157.
15. Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clinical Microbiology Reviews. 2014;27(4):870–926.
16. Gaudioso de Allori MC, Jure MA, Romero C, de Castillo MEC. Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biological and Pharmaceutical Bulletin. 2006;29(8):1592–1596.
17. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Wayne (PA): CLSI; 2024.